AJMC Staff

What we're reading, December 2, 2015: Gilead priced Sovaldi knowing the high cost would be a challenge for patients and payers; Senate Republicans will vote Thursday on Obamacare repeal and expect to get the needed votes; and a report calls for a better focus on women's health.

What we're reading, December 1, 2015: $1 alternative to Daraprim being made available; over-the-counter medications are convenient and affordable but have their own dangers; and an analysis looks at the reasons why prescription drugs are so much more expensive in the US.

What we're reading, November 30, 2015: the Spanish language HealthCare.gov is lagging in sign-ups; the overall federal insurance exchange has fewer preferred provider organizations; and many Americans don't understand why they need the flu vaccine.

The link between low testosterone and decreased insulin sensitivity had been shown in previous research.

Here are the top 5 papers published by The American Journal of Managed Care and its sister publications about hepatitis C, treatment, and costs of care.

What we're reading, November 25, 2015: UnitedHealthcare's decision on healthcare exchange participation, Democratic Presidential candidate's health plan, and conflict of interest between soda company and anti-obesity research group.

What we're reading, November 25, 2015: hospitals can save money in the long run by preventing hospital-acquired infections with private rooms; Arizona's co-op plans to close December 31; and study finds testing prison inmates for hepatitis C is extremely cost-effective.

What we're reading, November 26, 2015: CMS blog on step-wise transition to value-based care, payer-drug industry alliance on drug pricing, and a new model to override the proposed ACA tax credits.

What we're reading, November 24, 2015: expensive hepatitis C drugs are more cost effective when used earlier; clinicians aren't prescribing generics enough; and half of health 45-year-olds will develop prediabetes.

The study credited better drugs and improvements in foot inspections and self-care with the reduction.

What we're reading, November 23, 2015: Oregon and California both pass laws that authorize pharmacists to prescribe birth control; the US and Europe are approving more drugs; and Turing discounts Daraprim just 50% and only for hospitals.

What we're reading, November 20, 2015: CMS wants to penalize doctors for ordering routine prostate-cancer screening tests; lawmakers, patients, and advocates call for head of Drug Enforcement Agency to be fired; and specialty drug costs exceed household incomes.

What we're reading, November 19, 2015: the American Medical Association is calling for a ban on direct-to-consumer television advertisement of prescription drugs and popular silver plans on HealthCare.gov have largest premium increases.

What we're reading, November 18, 2015: global drug spending is expected to grow 30% in 5 years; Robert M. Califf, MD, sits through mostly friendly senate confirmation hearing for FDA nomination; and moderate coffee consumption could reduce some risks of death.

CMS has made available $32 million in funds to support efforts to further reduce the rate of uninsured children who are eligible for Medicaid or the Children's Health Insurance Program.

What we're reading, November 17, 2015: misunderstanding of antibiotics has fueled the rise of drug-resistant superbugs; healthcare leaders overwhelmingly support government intervention to curb rising cost of drugs; and the FDA wants more regulation on laboratory-developed tests.

What we're reading, November 16, 2015: consumers face sticker shock on Affordable Care Act plans when they get sick and face high deductibles; Medicare spending on hepatitis C drugs nearly doubled in 2015; and US maternal mortality has worsened since 1990.

Early sign-ups are strong under ACA; new food safety rules become final; report finds poor access to HIV drugs.

What we're reading, November 12, 2015: nationwide ban on smoking in public houses could have a huge economic impact; CMS barrier to sharing patient records on drug and alcohol abuse; an urgent care—ED hybrid model could save unnecessary costs.

What we're reading, November 11, 2015: annual flu shots may reduce the effectiveness of the vaccine; Democrats call for changes to the so-called Cadillac tax; and Millennium Health files for chapter 11 bankruptcy.

The approval comes after a priority review of the combination that blocks activity of 2 MAPK proteins: BRAF and MEK.

What we're reading, November 10, 2015: half of California's illegal immigrants would be eligible for Medi-Cal if it was expanded; women are less likely to receive optimal care after a heart attack, which accounts for survival gap; and Hawaii's residents face long wait times to sign up for health coverage on HealthCare.gov.

What we're reading, November 9, 2015: Americans worry patient-centered care is a gimmick; insurers raise new concerns over the increasing prices for generic drugs; and President Obama challenges 20 cities to sign up the most uninsured on the exchanges.

What we're reading, November 6, 2015: Americans want more aggressive measures to keep healthcare costs in check; the uninsured rate fell to 9% in the first half of 2015; and the federal government warns against restricting access to pricey hepatitis C drugs.

What we're reading, November 5, 2015: defensive medicine actually does reduce malpractice risk; patients would like more options for using digital technology with their healthcare; and Americans are eating healthier.

The bipartisan panel has asked 4 drug makers, including Turing Pharmaceuticals, to submit documents to the US Senate's Special Committee on Aging.

What we're reading, November 4, 2015: drug deaths become the next big 2016 presidential campaign issue; and Blue Shield of California and Anthem Blue Cross receive large fines for misleading information about Affordable Care Act Plans.

Approximately half of patients prescribed statins for lowering cholesterol discontinue use within the first year and the adherence rate only goes down from there.

Fifty organizations, including the American Society of Clinical Oncology, have expressed their confidence in Robert Califf, MD, to lead the FDA.

What we're reading, November 3, 2015: off-label drug use is associated with a higher risk of adverse drug events; CMS finalizes its rule for advanced care planning for end-of-life care; and Californians send measure to cut drug prices to the vote.